Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Cytarabine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cytarabine (liposomal) 50mg/5ml inj vials
0801030D0AAANAN
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 100mg/1ml solution for injection vials
0801030D0AAAHAH
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 100mg/5ml solution for injection vials
0801030D0AAAIAI
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 1g/10ml solution for injection vials
0801030D0AAAKAK
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 2g/20ml solution for injection vials
0801030D0AAALAL
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 4g/40ml solution for injection vials
0801030D0AAAPAP
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 500mg/25ml solution for injection vials
0801030D0AAAMAM
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 500mg/5ml solution for injection vials
0801030D0AAAJAJ
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 5g/50ml solution for infusion vials
0801030D0AAAQAQ
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.